Device Recall Spectrolyse PAI1 의 리콜

U.S. Food and Drug Administration에 따르면, 해당 리콜 는 United States 에서 Sekisui Diagnostics Llc 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    63016
  • 사례 위험등급
    Class 2
  • 사례 연번
    Z-2431-2012
  • 사례 시작날짜
    2012-08-28
  • 사례 출판 날짜
    2012-09-20
  • 사례 상황
    Terminated
  • 사례 국가
  • 사례 종료 날짜
    2016-07-25
  • 사례 출처
    USFDA
  • 사례 출처 URL
  • 비고 / 경고
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • 데이터 추가 비고
    Test, qualitative and quantitative factor deficiency - Product Code GGP
  • 원인
    Spectrolyse pai-1 activity assay producing lower than expected absorbance values with "0" standard. this will reduce the slope of the standard curve requiring the user to make more frequent sample dilutions.
  • 조치
    The firm, Sekisui Diagnostics, LLC, sent an "URGENT PRODUCTS RECALL NOTICE" dated August 28, 2012 to its customers. The notice describes the product, problem and actions to be taken. The customers were instructed to immediately stop using the product; to discard any remaining inventory and complete and return the Customer Acknowledgement Form by September 4, 2012 documenting the # of kits destroyed via FAX to Quality Assurance at 203-602-5553. The customers were also instructed to return the form even if they do not have the affected product currently in inventory. Sekisui will replace kits. If you have any questions contact, Customer Service Department at 800-637-3375, ext 10, 12, or 31, or email to recall coordinator at MKHAN@AMDIAG.COM.

Device

  • 모델명 / 제조번호(시리얼번호)
    Lot Numbers: 120425 and 120601
  • 의료기기 분류등급
  • 의료기기 등급
    2
  • 이식된 장치?
    No
  • 유통
    Nationwide distribution: USA including states of: FL, IN, IL, and WA.
  • 제품 설명
    Sekisui Spectrolyse PAI-1, In-Vitro Diagnostic for Quantitative determination of Plasminogen Activator Inhibitor Type- 1 (PAI-1) activity in human plasma. || Catalog Number: 101201 || For the determination of Plasminogen Activator Inhibitor Type 1 (PAI-1) activity in human plasma. The test is for in Citro diagnostic use.
  • Manufacturer

Manufacturer

  • 제조사 주소
    Sekisui Diagnostics Llc, 500 West Avenue, Stamford CT 06902
  • 제조사 모회사 (2017)
  • Source
    USFDA